Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
2.
Org Biomol Chem ; 8(5): 1064-80, 2010 Mar 07.
Artigo em Inglês | MEDLINE | ID: mdl-20165797

RESUMO

The development of a Lewis acid-promoted aza-Prins reaction to form piperidines and pyrrolidines is described. Indium trichloride has been found to be a highly successful and mild Lewis acid for promoting this reaction. A thorough mechanistic investigation is described, including the factors that influence the formation of the 5- or 6-membered ring product(s).


Assuntos
Piperidinas/química , Pirrolidinas/química , Ciclização , Modelos Moleculares , Estrutura Molecular , Estereoisomerismo
3.
Bioorg Med Chem ; 16(18): 8492-500, 2008 Sep 15.
Artigo em Inglês | MEDLINE | ID: mdl-18752965

RESUMO

Novel racemic indeno[1,2-e]pyrimido[4,5-b][1,4]diazepine-5,11-diones 3-29 were obtained regioselectivily from the reaction of 5,6-diamino-3,4-dihydropyrimidin-4-ones 1 and 2-arylideneindandiones 2 as reagents. These compounds have been evaluated at the US National Cancer Institute (NCI) for their ability to inhibit approximately 60 different human tumor cell lines, where 5 and 6 presented remarkable activity against 57 and 48 cancer cell lines, respectively, with the most important GI(50) values ranging from 0.49 to 1.46 microM, in vitro assay.


Assuntos
Antineoplásicos/farmacologia , Azepinas/farmacologia , Dibenzazepinas/química , Indóis/química , Pirimidinas/química , Pirimidinonas/farmacologia , Antineoplásicos/síntese química , Azepinas/síntese química , Linhagem Celular Tumoral/efeitos dos fármacos , Humanos , Concentração Inibidora 50 , Pirimidinonas/síntese química , Relação Estrutura-Atividade
4.
Bioinorg Chem Appl ; : 654137, 2008.
Artigo em Inglês | MEDLINE | ID: mdl-18401456

RESUMO

A novel tri-n-butyl(IV) derivative of 2-thiobarbituric acid (HTBA) of formula [(n-Bu)(3)Sn(TBA) H(2)O] (1) has been synthesized and characterized by elemental analysis and (119)Sn-NMR and FT-IR spectroscopic techniques. The crystal structure of complex 1 has been determined by single crystal X-ray diffraction analysis at 120(2) K. The geometry around Sn(IV) is trigonal bipyramidal. Three n-butyl groups and one oxygen atom from a deprotonated 2-thiobarbituric ligand are bonded to the metal center. The geometry is completed with one oxygen from a water molecule. Compound 1 exhibits potent, in vitro, cytotoxicity against sarcoma cancer cells (mesenchymal tissue) from the Wistar rat, polycyclic aromatic hydrocarbons (PAH, benzo[a]pyrene) carcinogenesis. In addition, the inhibition caused by 1, in the rate of lipoxygenase (LOX) catalyzed oxidation reaction of linoleic acid to hyperoxolinoleic acid, has been also kinetically and theoretically studied. The results are compared to that of cisplatin.

5.
J Med Chem ; 47(22): 5482-91, 2004 Oct 21.
Artigo em Inglês | MEDLINE | ID: mdl-15481985

RESUMO

The synthesis of a series of novel 1-(2-deoxy-4-thio-beta-D-erythro-pentofuranosyl)-(6-azapyrimidine) nucleosides is described. X-ray crystallographic data of the thymidine derivative allowed conformational analysis, which indicated a twist (3T2) sugar conformation. Hydrogen-bonded assemblies for the crystal structure were determined using PLATON software to allow further interpretation of the crystal packing and base interactions. The 6-azapyrimidine nucleosides described were evaluated against a range of viral strains. The thymidine analogue showed pronounced activity against herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2), varicella-zoster virus (VZV), and vaccinia virus. This compound lost only 5- to 10-fold of its antiviral activity against thymidine kinase (TK)-deficient HSV-1 and VZV strains. These observations suggest that the compounds may not entirely depend on viral TK-catalyzed phosphorylation for antiviral activity and/or use an alternative metabolic activation pathway, and/or display a unique mechanism of antiviral action by the unmetabolized nucleoside analogue.


Assuntos
Antivirais/síntese química , Herpesvirus Humano 3/efeitos dos fármacos , Pirimidinas/síntese química , Simplexvirus/efeitos dos fármacos , Tionucleosídeos/síntese química , Timidina Quinase/genética , Animais , Antivirais/química , Antivirais/farmacologia , Linhagem Celular , Cristalografia por Raios X , Herpesvirus Humano 1/efeitos dos fármacos , Herpesvirus Humano 1/enzimologia , Herpesvirus Humano 2/efeitos dos fármacos , Herpesvirus Humano 2/enzimologia , Herpesvirus Humano 3/enzimologia , Humanos , Modelos Moleculares , Conformação Molecular , Pirimidinas/química , Pirimidinas/farmacologia , Simplexvirus/enzimologia , Relação Estrutura-Atividade , Tionucleosídeos/química , Tionucleosídeos/farmacologia , Timidina Quinase/química
6.
Chem Commun (Camb) ; (20): 2552-3, 2003 Oct 21.
Artigo em Inglês | MEDLINE | ID: mdl-14594276

RESUMO

Silylated methylenecyclopropyl hydrazones on treatment with BF3 x Et2O cyclise to give heterocyclic products involving a novel sequence of hydride and silyl shifts via a series of increasingly stable cationic intermediates.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...